These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28898712)

  • 1. Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.
    Toth Z; Smindak RJ; Papp B
    Virology; 2017 Dec; 512():25-33. PubMed ID: 28898712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
    Li D; Mosbruger T; Verma D; Swaminathan S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.
    Chen HS; Wikramasinghe P; Showe L; Lieberman PM
    J Virol; 2012 Sep; 86(17):9454-64. PubMed ID: 22740398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription.
    Li DJ; Verma D; Mosbruger T; Swaminathan S
    PLoS Pathog; 2014 Jan; 10(1):e1003880. PubMed ID: 24415941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.
    Kang H; Lieberman PM
    J Virol; 2009 Jun; 83(12):6199-210. PubMed ID: 19369356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.
    Kang H; Wiedmer A; Yuan Y; Robertson E; Lieberman PM
    PLoS Pathog; 2011 Aug; 7(8):e1002140. PubMed ID: 21876668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
    Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
    PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.
    Toth Z; Brulois K; Lee HR; Izumiya Y; Tepper C; Kung HJ; Jung JU
    PLoS Pathog; 2013; 9(12):e1003813. PubMed ID: 24367262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRC1-independent binding and activity of RYBP on the KSHV genome during de novo infection.
    Lee SC; Toth Z
    PLoS Pathog; 2022 Aug; 18(8):e1010801. PubMed ID: 36026503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
    Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
    Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.
    Gong D; Dai X; Xiao Y; Du Y; Chapa TJ; Johnson JR; Li X; Krogan NJ; Deng H; Wu TT; Sun R
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators.
    Stedman W; Kang H; Lin S; Kissil JL; Bartolomei MS; Lieberman PM
    EMBO J; 2008 Feb; 27(4):654-66. PubMed ID: 18219272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic analysis of KSHV latent and lytic genomes.
    Toth Z; Maglinte DT; Lee SH; Lee HR; Wong LY; Brulois KF; Lee S; Buckley JD; Laird PW; Marquez VE; Jung JU
    PLoS Pathog; 2010 Jul; 6(7):e1001013. PubMed ID: 20661424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.